The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
07 Feb 2020
Results of the Contest of Best Practices tackling social inequalities in cancer prevention
iPAAC partner FISABIO (Fundació per al Foment de la Investigació Sanitaria I Biomèdica de la Comunitat Valenciana) launched in 2019 a Contest of Best Practices tackling social inequalities in cancer prevention, including both health promotion and cancer screening programmes.
04 Feb 2020
Future Europe's Beating Cancer Plan supported by the activities of Joint Actions Against Cancer (EPAAC, CANCON, iPAAC)
Tackling cancer is one of the von der Leyen Commission’s main priorities in the area of health, since data shows that the number of cancer cases in the EU will double by 2035.
26 Jan 2020
New openings of cancer screening in Europe
The iPAAC WP5 conference, side event of Finland’s Presidency of the Council of the European Union, was held on 5 December 2019 in Helsinki.
11 Nov 2019
3rd Governmental Board meeting
The 3rd iPAAC Governmental Board meeting took place on 9 and 10 October 2019 in Barcelona.